Sequent Scientific Limited — Important, 30-04-2025: General Updates

Alivira Animal Health Limited has completed the acquisition of 5,700 shares in Provet Veteriner Urunleri Sanayi Ve Ticaret A.S. for TL 57,000,000 (approximately ₹12.54 crore). This move enhances SeQuent Scientific's operational capacity in the veterinary products sector, with Provet reporting a turnover of around ₹103.30 crore in FY 2023-24. The investment bolsters SeQuent’s presence and capabilities in the Turkish market, reinforcing growth potential in this segment.